bioRxiv · 10.1101/042481
The Plasmodium falciparum drugome and its polypharmacological implications
Abstract
Malaria is a disease contracted by over 200 million people each year, mostly in developing countries. The primary causative agent, Plasmodium falciparum (P. falciparum) has shown increased resistance to existing drugs, hence new treatments are needed quickly. To this end we performed a high-throughput systems-level analysis, mapping existing FDA drugs with the potential for repurposing against targets from the P. falciparum structural proteome. The resulting P. falciparum drugome (P.falciparum-drugome) was used to prioritize potential new anti-malaria candidate targets and highlight some novel FDA approved drugs that have apparent anti-malaria effects for possible use as multi-target therapeutics.
Explore related subjects
Keep this discovery
Yinliang Zhang, Li Xie, Lei Xie, Philip Bourne. 2016-03-05. The Plasmodium falciparum drugome and its polypharmacological implications. https://doi.org/10.1101/042481
Cite the original work for its findings. Save a collection to share your selection of sources.